Skip to main content
KLRS
NASDAQ Life Sciences

Kalaris Extends Cash Runway Into 2028, But TH103 Data Slips to 2H 2027

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$2.304
Mkt Cap
$50.233M
52W Low
$1.78
52W High
$11.88
52W Position info
29% above low
Off High info
81% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

KLRS sits 29% above its 52-week low of $1.78.

Summary

Kalaris ended Q3 with $82.9M in cash and securities, down from $118.0M at year-end 2025, and now says that funds operations into 2028 — a year beyond the Q4 2027 runway it reiterated in its August 10-Q. The Q3 net loss narrowed to $11.0M from $11.9M a year ago. The tradeoff: preliminary TH103 data is now expected in 2H 2027, pushing the key clinical readout further out for a Phase 1b/2 asset, and a potential Phase 3 program is now expected in 2028. The company also completed its commercial-scale manufacturing transfer, with test batches hitting targets, though no Phase 3 supply or commercial production is reported. With a $350M shelf and $100M ATM already in place, the extended runway reduces near-term financing pressure but the delayed readout leaves little to move the stock before 2027.

At the time of this announcement, KLRS was trading at $2.30 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $50.2M. The 52-week trading range was $1.78 to $11.88. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

KLRS - Latest Insights

KLRS
Nov 10, 2026, 4:00 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.85
Real-time Price: $1.58 info
Change: -$0.275 (-15%) info
Market Cap: $34.398M info
KLRS
Aug 11, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.27
Real-time Price: $1.58 info
Change: -$2.69 (-63%) info
Market Cap: $34.398M info
KLRS
Jul 17, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.66
Real-time Price: $1.58 info
Change: -$3.09 (-66%) info
Market Cap: $34.398M info
KLRS
Jul 17, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $4.58
Real-time Price: $1.58 info
Change: -$3.01 (-66%) info
Market Cap: $34.398M info
KLRS
Jun 23, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.40
Real-time Price: $1.58 info
Change: -$2.83 (-64%) info
Market Cap: $34.398M info